ArticleBlood2014

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.

Holbrook E Kohrt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.